Influences of Socioeconomic Status on Costs of Asthma Under Universal Health Coverage
Datos Bibliográficos
| ID | 9102323 |
|---|---|
| Autores | Wenjia Chen (0000-0001-8201-7145, Collaboration for Outcomes Research and Evaluation, Faculty of Pharmaceutical Sciences, autor de correspondencia), Larry D Lynd (0000-0002-7622-3919, Collaboration for Outcomes Research and Evaluation, Faculty of Pharmaceutical Sciences, autor de correspondencia), J Mark FitzGerald (0000-0002-5367-5226, University of British Columbia), Mohsen Sadatsafavi (0000-0002-0419-7862, University of British Columbia) |
| Año | 2016 |
| Volumen | 54 |
| Número | 8 |
| Páginas | 789-795 |
| Fecha de publicación | 2016-08-01 |
| Peer Reviewed | Sí |
| Open Access | No |
| Tipo | ARTICLE |
| Revista | Medical Care (JOURNAL) |
| Identificadores de la revista | ISSN: 0025-7079 • E-ISSN: 1537-1948 |
| Editorial | Ovid Technologies (Wolters Kluwer Health) (PUBLISHER) |
| DOI | 10.1097/mlr.0000000000000563 |
| PMID | 27213543 |
| OpenAlex | W2406703779 |
| Idioma | EN |
| Referencias citadas | 27 |
BACKGROUND: Despite Canada's provision of universal health coverage, socioeconomic barriers to good-quality health care remain. Asthma provides an appropriate case study given its high prevalence, availability of effective controller therapies, and known variations in care. OBJECTIVES: The aim of this study is to examine the extent of differences in the economic burden of asthma and indicators of guideline-based care across socioeconomic status (SES) gradients. RESEARCH DESIGN: A total of 29,283 adults with moderate to severe asthma were identified from British Columbia's administrative health data for the year 1997-2013 and were matched to adults without asthma on the basis of sex and age. Direct medical costs (in 2013 Canadian dollars, $) included all-cause inpatient, outpatient, and pharmacy costs. SES was measured at individual (receiving social assistance) and aggregate (median neighborhood household income) levels. We assessed the impact of SES on excess direct costs of asthma (the difference in all-cause direct medical costs between an asthma patient and the matched individual), and on use of asthma controller versus reliever medications. Associations were evaluated using generalized linear models. RESULTS: Asthmatics receiving social assistance incurred $706 (95% confidence interval, $302-$1014) higher annual excess costs than the rest of the sample. Annual excess costs were $120 ($18-$168) higher in low-SES versus high-SES neighborhoods. Low SES, at both individual and aggregate levels, was consistently associated with lower expenses on controller medications and higher expenses on reliever medications, indicators of suboptimal asthma care and control. CONCLUSION: Even under universal health care, individuals in lower SES groups did not receive guideline-based asthma care, potentially explaining their higher costs
Asthma · Confidence interval · Environmental health · Family medicine · Health care · Population · Socioeconomic status · Asthma and respiratory diseases · Demography · Health Promotion and Cardiovascular Prevention · Healthcare Systems and Reforms · Medicine · Pharmacy
Socioeconomic Status and Health
Access to Care Is the Centerpiece in the Elimination of Socioeconomic Disparities in Health
Can patient self-management help explain the SES health gradient?
Social determinants of health inequalities
A new method of classifying prognostic comorbidity in longitudinal studies
Socioeconomic disparities in health care use
Smoking by blacks and whites
Using G-Computation to Estimate the Effect of Regionalization of Surgical Services on the Absolute Reduction in the Occurrence of Adverse Patient Outcomes
Socioeconomic Status and Mental Illness
Neighborhood effects on primary care access in Los Angeles
| Velocidad de citación | historical |
|---|---|
| Altamente citado | No |